Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
Trade this ETF at your broker
Index | MSCI ACWI IMI Genomic Innovation Select Screened 100 |
Investment focus | Equity, World, Health Care, Social/Environmental |
Fund size | EUR 3 m |
Total expense ratio | 0.30% p.a. |
Replication | Physical (Full replication) |
Legal structure | ETF |
Strategy risk | Long-only |
Sustainability | Yes |
Fund currency | USD |
Currency risk | Currency unhedged |
Volatility 1 year (in EUR) | 17.02% |
Inception/ Listing Date | 12 July 2022 |
Distribution policy | Accumulating |
Distribution frequency | - |
Fund domicile | Ireland |
Fund Provider | Xtrackers |
Fund Structure | Company With Variable Capital (SICAV) |
UCITS compliance | Yes |
Administrator | State Street Custodial Services (Ireland) Limited |
Investment Advisor | DWS Investments UK Limited |
Custodian Bank | State Street Custodial Services (Ireland) Limited, Dublin 2 |
Revision Company | Pricewaterhouse Coopers |
Fiscal Year End | 31 December |
Swiss representative | DWS CH AG |
Swiss paying agent | Deutsche Bank (Suisse) SA |
Tax data | Bundesanzeiger | |
Germany | 30% tax rebate | |
Switzerland | ESTV Reporting | |
Austria | Tax Reporting Fund | |
UK | UK Reporting |
Indextype | - |
Swap counterparty | - |
Collateral manager | |
Securities lending | Yes |
Securities lending counterparty |
Agilent Technologies | 4.91% |
Natera | 4.80% |
Abbott Laboratories | 4.79% |
Bristol Myers Squibb Co. | 4.71% |
Thermo Fisher Scientific, Inc. | 4.71% |
Danaher Corp. | 4.67% |
Lonza Group AG | 4.60% |
Illumina, Inc. | 4.49% |
Roche Holding AG | 4.43% |
Vertex Pharmaceuticals | 3.96% |
United States | 77.96% |
Switzerland | 10.05% |
China | 3.16% |
Other | 8.83% |
Health Care | 94.36% |
Other | 5.64% |
Broker | Rating | Execution fee | Account fee | |
---|---|---|---|---|
![]() | 0.00€ | 0.00€ | View offer* | |
![]() | 0.00€ | 0.00€ | View offer* | |
![]() | 0.00€ | 0.00€ | View offer* | |
![]() | 0.00€ | 0.00€ | View offer* | |
![]() | 0.00€ | 0.00€ | View offer* |
Broker | Rating | Order fee | ETF savings plans | |
---|---|---|---|---|
![]() | 0.00€ | 2613 | View offer* | |
![]() | 1.00€ | 2408 | View offer* | |
![]() | 0.00€ | 1684 | View offer* | |
![]() | 0.00€ | 1639 | View offer* | |
![]() | 0.00€ | 1068 | View offer* |
YTD | -5.05% |
1 month | -6.23% |
3 months | -7.44% |
6 months | -6.82% |
1 year | -4.26% |
3 years | - |
5 years | - |
Since inception (MAX) | -18.61% |
2024 | +3.99% |
2023 | -7.06% |
2022 | - |
2021 | - |
Volatility 1 year | 17.02% |
Volatility 3 years | - |
Volatility 5 years | - |
Return per risk 1 year | -0.25 |
Return per risk 3 years | - |
Return per risk 5 years | - |
Maximum drawdown 1 year | -11.16% |
Maximum drawdown 3 years | - |
Maximum drawdown 5 years | - |
Maximum drawdown since inception | -32.46% |
Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
---|---|---|---|---|---|
gettex | EUR | XGEN | - - | - - | - |
Borsa Italiana | EUR | XGEN | XGEN IM XGENEUIV | XGEN.MI XGENEURINAV=SOLA | |
London Stock Exchange | USD | XGEN | XGEN LN XGENUSIV | XGEN.L XGENUSDINAV=SOLA | |
London Stock Exchange | GBP | XGES | XGES LN XGENCHIV | XGES.L XGENCHFINAV=SOLA | |
SIX Swiss Exchange | CHF | XGEN | XGEN SW XGENGBIV | XGEN.S XGENGBPINAV=SOLA | |
XETRA | EUR | XGEN | XGEN GR | XGEN.DE |
Fund name | Fund Size in m € (AuM) | TER p.a. | Distribution | Replication |
---|---|---|---|---|
iShares Healthcare Innovation UCITS ETF | 973 | 0.40% p.a. | Accumulating | Sampling |
VanEck Genomics and Healthcare Innovators UCITS ETF A | 5 | 0.35% p.a. | Accumulating | Full replication |